Indian Medical Value Travel (MVT) projects to surpass USD13 bn by 2026; valued at USD 6 bn in 2022: Tourism Minister
Union Minister of Tourism and Culture, Government of India, Gajendra Singh Shekhawat
The 6th edition of ‘FICCI Medical Value Travel Awards’ was graced by the presence of by Union Minister of Tourism and Culture, Government of India, Gajendra Singh Shekhawat and other dignitaries.
The 6th edition of ‘FICCI Medical Value Travel Awards’ has been organised during the 8th edition of Advantage Healthcare India 2026. The event was graced by the presence of by Union Minister of Tourism and Culture, Government of India, Gajendra Singh Shekhawat; Election Commissioner for the Union Territories & Jury Chair, FICCI Medical Value Travel Awards, Sudhanshu Pandey (Retd.); and other dignitaries.
The awards recognise the excellence, innovation, and leadership across hospitals, facilitators, AYUSH institutions, wellness providers, and policymakers contributing to India’s growing prominence in the global healthcare landscape.
Speaking on the occasion, Union Minister of Tourism and Culture, Shekhawat, said, “The sector, valued at approximately USD 6 billion in 2022, is projected to surpass USD 13 billion by 2026. This growth is the result of sustained efforts by healthcare providers, facilitators, policymakers, and industry bodies such as FICCI.”
“Under the leadership of Hon’ble Prime Minister Shri Narendra Modi, India is moving with a clear and confident vision to become the world’s most trusted hub for healthcare and wellness. Medical Value Travel is not merely a sector of economic growth; it reflects India’s civilisational ethos of healing with compassion and serving humanity with excellence,” he added
Sudhanshu Pandey (Retd.), Election Commissioner for the Union Territories & Jury Chair, FICCI Medical Value Travel Awards, said, “Nearly a decade ago, when healthcare was identified among India’s Champion Sectors, the objective was clear, to give global patients a structured, credible, and organised ecosystem rather than a fragmented experience. The institution of these Awards was a natural progression of that vision, to benchmark excellence and encourage continuous improvement.”
He further stated that as competition intensifies and standards rise, the next phase of growth will depend on institutional discipline, particularly with stronger internal systems, data integrity, and documentation practices that align with global expectations. Sustained leadership in Medical Value Travel will come not only from clinical excellence, but from systemic maturity, he added.
“India’s healthcare outreach is entering a defining decade, powered by capability, collaboration, and global confidence. As participation expands and partnerships deepen, we are not only showcasing excellence but strengthening India’s standing as a preferred international destination for advanced and comprehensive medical care,” said, Dr Raajiv Singhal, Chair, FICCI Medical Value Travel Committee; Founding Member, MD & Group CEO, Marengo Asia Healthcare.
Kabiir Khattar, Associate Vice President, EY said, “As India’s Medical Value Travel ecosystem continues to scale globally, it is imperative that institutions strengthen their internal documentation, data integrity, and compliance standards to ensure sustained trust and international credibility.”
Dr Ravi Gaur, Founder DRG Path Labs while delivering the vote of thanks congratulated to the award winners for exemplifying excellence in India’s healthcare ecosystem.
